Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 1999

View Archived Issues

BCH-2763 shows antithrombotic activity in canine model of DVT

Bio-Rad finalizes acquisition of Pasteur Sanofi Diagnositics

Genome Therapeutics reaches milestone in antifungal alliance with Schering-Plough

Phase I/II results support further development of Leuvectin

Progenics' PRO-140 shown to be potent HIV inhibitor

Schein to license proprietary chelating compound from SunPharm

Duramed and Solvay team up to promote hormone products

Anesta licenses Actiq rights to Elan

AEterna accelerates clinical development of AE-941

Cantab licenses anti-OX40 antibodies to Celltech

FDA gives go-ahead for phase II clinical trial of ML Laboratories' AIDS treatment

Solvay launches Aceon tablets in the U.S. for 24-hour control of hypertension

FDA advisory committee to review Visudyne NDA

New MMP inhibitors from Leo reportedly superior to structurally related compounds

Apotex describes new inhibitors of cysteine proteases in recent patent literature

NC-100100 is safe and well tolerated in target group of patients

Steroid antibacterials with the added ability to increase susceptibility to other antibiotics

FDA approves seven-day HRT patch

Searle's new amino acid derivatives preferentially inhibit iNOS

Extensive coverage of ABT-773, a novel ketolide, at the ICAAC meeting

Timetable for creation of Aventis revealed this week

Japanese researchers isolate and characterize two related immunosuppressants

Licensing opportunity from NIH: calcium channel modifiers with application in HIV and AIDS

Immunostimulatory oligonucleotide enhances immune response to HBV vaccine in animals

Sepracor obtains rights to develop hypnotic agent in U.S.

PMS-601: a PAF antagonist with potential as a new adjuvant AIDS therapy

Synthesis and activity of potent, selective sigma1 ligands reported by Taisho

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...